Why Sucampo Pharmaceuticals, Inc. Shares Jumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of Sucampo Pharmaceuticals , a biopharmaceutical company focused on developing therapies utilizing prostones and other novel technologies, jumped as much as 19% after the company reported its fourth-quarter earnings results after the bell last night.
So what: For the quarter, Sucampo reported a 30% decline in total revenue to $24.5 million, which it noted was due to the receipt of a $15 million milestone payment associated with the launch of long-term constipation treatment Amitiza in Japan last year. Excluding this milestone payment, organic revenue gained 23%, aided most by a 215% improvement in Amitiza sales in Japan. More importantly, Sucampo reported a GAAP profit of $0.05 per share, which was considerably better than the $0.02 loss per share that Wall Street expected.
Now what: Based on this quarterly report, it looks as if Amitiza sales are really beginning to take off around the world. As long as Sucampo can control its expenses, it should be able to simply coast into profits since its partner Takeda Pharmaceuticals is handling all of the marketing aspects in the United States. With easy double-digit top-line growth potential and a minuscule forward P/E of just 15 following today's romp higher, I'd suggest that there could still be additional upside in shares of Sucampo.
Sucampo shares may be soaring today, but they'll probably have a difficult time keeping up with this top stock in 2014
There's a huge difference between a good stock and a stock that can make you rich. The Motley Fool's chief investment officer has selected his No. 1 stock for 2014, and it's one of those stocks that could make you rich. You can find out which stock it is in the special free report "The Motley Fool's Top Stock for 2014." Just click here to access the report and find out the name of this under-the-radar company.
The article Why Sucampo Pharmaceuticals, Inc. Shares Jumped originally appeared on Fool.com.
Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.The Motley Fool has no position in any companies mentioned in this article. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2014 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.